Risk stratification of pancreatic cancer by a blood test for apolipoprotein A2-isoforms.

Authors:
Honda K.

Journal:
Cancer Biomark

Publication Year: 2022

DOI:
10.3233/CBM-210198

PMCID:
PMC9108558

PMID:
35491769

Journal Information

Full Title: Cancer Biomark

Abbreviation: Cancer Biomark

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biochemistry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"These studies were supported by grants from the Project for Cancer Research and Therapeutic Evaluation (P-CREATE) (20cm0106403h0005), the Practical Research for Innovative Cancer Control Program (19ck0106280h0003 and 21ck0106661h0001), and AMED CREST (19gm0710013h0306) from the Japan Agency for Medical Research and Development (AMED)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025